Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine maintenance in stage IIIC/IV colorectal cancer
NCT01880658Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2013
- Primary completion
- May 2016
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
capecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01880658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880658.